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Abstract.  The carboxy-terminal tail of nucleoplasmin, 
which specifies entry into the cell nucleus, contains 
four short sequences that are similar to previously 
identified nuclear location sequences. We show that 
none of these is able to locate chicken muscle pyru- 
vate kinase to the cell nucleus.  Deletion analysis was 
used to determine the limits of a  nuclear location se- 
quence and indicated that a  14-amino acid segment 
(RPAATKKAGQAKKK) should function as a  minimal 
nuclear location sequence. When tested directly, how- 
ever, this sequence was  unable to locate pyruvate ki- 
nase to the cell nucleus.  Restoration of three amino 
acids of nucleoplasmin sequence at either end of this 
sequence generated sequences that were able to locate 
pyruvate kinase to the cell nucleus. 
The  14-amino acid proposed minimal  nuclear loca- 
tion sequence is present in the functional sequences, 
AVKRPAATKKAGQAKKK, RPAATKKAG- 
QAKKKKLD, and the sequence AVKRPAATKKAG- 
QAKKKKLD, which has additional amino acids at 
both ends.  The minimal  sequence element is therefore 
necessary but not sufficient for transport into the cell 
nucleus.  This unusual  feature of the nucleoplasmin nu- 
clear location sequence suggests ways in which it 
could interact with the nuclear transport mechanism. 
I 
N addition to its established role in chromatin assembly 
and histone storage in the Xenopus oocyte and egg (4, 
16,  18, 21), nucleoplasmin has emerged as the protein 
of choice for studies of protein transport into the cell nucleus 
(reviewed in reference 5).  Investigations using this acidic, 
thermostable, pentameric protein provided the decisive evi- 
dence that a mechanism of uptake involving selective entry 
into the nucleus operates in oocytes (8). 
Nucleoplasmin has also been used to demonstrate that en- 
try into the Xenopus oocyte nucleus occurs through the nu- 
clear pore complex (9), to evaluate the transport properties 
of nuclei reconstituted in vitro, and to show that ATP is re- 
quired for the transport process (28). 
Primary amino acid sequences specifying entry into the 
nucleus have been identified in a number of proteins (5, 23, 
25, 30). The sequence that has been studied in greatest mo- 
lecular detail is the SV-40 large T antigen nuclear location 
sequence (3,  11,  14,  15,  19, 20, 33, 37).  The earlier studies 
in  this  series demonstrated that the  amino  acid  sequence 
PKK~28KRKV is able to translocate chicken muscle pyru- 
vate kinase to the cell nucleus (15). 
The chicken muscle pyruvate kinase expression vector sys- 
tem has also been used to map the polyoma virus large T nu- 
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clear location sequences (32) and more recently to inves- 
tigate the effect of protein context upon the function of the 
SV-40 large T antigen nuclear location sequence (33). There- 
fore we chose this system to identify the nuclear location se- 
quence or sequences in the nucleoplasmin "tail" region since 
a large body of data exists against which we can interpret our 
results. 
We have sequenced nucleoplasmin and shown that the tail 
region which is both necessary and sufficient for selective 
entry of nucleoplasmin into the nucleus corresponds to the 
carboxy-terminal 50 amino acids (6, 7). In addition we have 
pointed out the presence of four sequences in the tail region 
which show significant degrees of similarity to other nuclear 
location sequences (6, 7). 
Recently Burglin and De Robertis (1) have shown that one- 
half of the tail region of nucleoplasmin can translocate Esch- 
erichia coli I~-galactosidase  to the Xenopus oocyte nucleus. 
This region includes a sequence which bears a striking simi- 
larity to the SV-40 large T antigen nuclear location sequence, 
differing only by two amino acid substitutions. Each of these 
substitutions alone still allows the SV-40 large T antigen se- 
quence to locate the protein to the cell nucleus (37). 
Here we describe the construction of recombinant plas- 
mids in which portions of the nucleoplasmin tail region are 
linked to the chicken muscle pyruvate kinase cDNA.  We 
confirm that the entire nucleoplasmin tail region can translo- 
care a cytoplasmic protein to the cell nucleus (in agreement 
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this activity lies in the amino-terminal half of the tail. We 
find, however that the sequence in this half of the tail region 
which most strongly resembles the SV-40 nuclear location 
sequence is unable to locate chicken muscle pyruvate kinase 
to the cell nucleus when fused to the carboxy or amino termi- 
nus of the protein. In fact none of the four sequences similar 
to other nuclear location sequences that we have observed 
and discussed previously (1, 6, 7) is capable of translocating 
pyruvate kinase to the cell nucleus. 
Deletion analysis  reveals that a  single  sequence in  the 
nucleoplasmin tail region is capable of translocating pyru- 
vate kinase to the nucleus. However this sequence is longer 
and more complex than previously identified nuclear loca- 
tion  sequences.  The  unusual  properties  of this  sequence 
suggest a model for the interaction of the nuclear location se- 
quence with  the  putative receptor in the transport mech- 
anism. 
Materials and Methods 
Microinjection 
Vero (African Green Monkey) cells were grown on glass coverslips and 
microinjected using glass capillaries as described previously (12, 31). Plas- 
mid DNAs were injected at a concentration of 100 ~tg/ml into the nucleus 
delivering ,'~1,000 molecules/cell. Proteins at a concentration of 1 mg/ml 
were injected into the nucleus or cytoplasm of the cell delivering on the or- 
der of 106 molecules/cell. 
Immunofluorescence Microscopy 
Nucleoplasmin/pyruvate kinase fusion proteins were detected with rabbit 
polyclonal antiserum raised against purified chicken muscle type M1 pyru- 
vate kinase (22) followed by FITC-conjugated goat anti-rabbit IgG (Nordic 
Immunological Labs. Ltd., Maidenhead, UK) or with a mixture of mono- 
clonal antibodies to the tail region of nucleoplasmin (7) followed by FITC- 
conjugated rabbit anti-mouse IgG. 
Proteins 
Nucleoplasmin, the trypsin resistant core of nucleoplasmin and the 12-kD 
tail fragment of nucleoplasmin were all prepared using previously published 
procedures (8). 
Plasmid Construction 
Vector Fragments. The materials and methods for plasmid construction are 
identical to those described previously (15, 32,  33). 
Nucleoplasmin  Fragments.  An  M13  clone  containing  a  full-length 
nucleoplasmin cDNA (7) with Eco R1 linkers was used as the start material 
for the production of nucleoplasmin DNA fragments. All procedures used 
were conventional techniques described in detail elsewhere (24). 
pPK-NP1.  A  fragment  encompassing  the  tail  region  (amino  acids 
149-200)  was prepared by digestion of 1 tag of the M13 clone (RF) with 
Hinf I, repaired with DNA polymerase (Klenow) and addition of an Xho 
I linker.  The required Xho-Pk fragment was purified from an acrylamide 
gel and ligated to the appropriate vector fragment (see below) to produce 
plasmid pPK-NP1. The fragment was also ligated into a pUC  13 vector in 
which an Xho linker had been inserted into the Hinc II site in the polylinker 
(a gift from T. J. Mohun, Zoology, Cambridge, UK) to produce pUC-NP1. 
pPK-NP2.  1 Izg of the pUC13 subelone described above (pUC13-NP1) 
was digested with Sac I, repaired with the T4 DNA polymerase and an Xho 
I linker added. The required Xho-Eco RI fragment encoding amino acids 
178-200  was purified from an acrylamide gel and ligated to the appropriate 
vector fragments. 
pPK-NP3.  1 lag of pUC13-NP1 was digested with Xho I and Sac I and 
the DNA fragment encoding amino acids  149-176  of nucleoplasmin was 
purified from a polyacrylamide gel and ligated into suitably cleaved pUC 
13. The subclone produced was digested with Sac I, and repaired with T4 
DNA  polymerase.  Universal translation terminator linkers (GCTTAAT- 
TAATTAAGC;  Pharmacia, Inc., Piscataway, N  J) were added to the repaired 
DNA. The linear plasmid DNA was purified from an agarose gel and then 
ligated to form circular molecules. A recombinant plasmid (pUC 13-NP3) 
was identified which had the required nucleoplasmin fragment and a univer- 
sal terminator linker.  After digestion with Xho I and Eco RI this fragment 
was purified from an acrylamide gel and ligated to the appropriate vector 
fragments to produce pPK-NP3. 
pPK-NP4.  1 lag of the plasmid pUCI3-NP3 was digested with Bst N1, 
repaired  with  DNA  polymerase large  fragment,  and  Xho  linkers were 
added. The DNA was digested with Xho I and Eco RI and the DNA frag- 
ment encoding amino acids 165-176 of nucleoplasmin was purified from an 
acrylamide gel and ligated to the appropriate vector fragments to produce 
pPK-NP4. 
pNP4-PK. An Xho I-Eco RI fragment encoding amino acids  165-176 
was ligated in a three fragment ligation with a Barn HI-Xho I fragment from 
XSRL 40 and an Eco RI-Bam HI fragment from RL18  PKI2 to link the 
nucleoplasmin sequence at the amino terminus of pyruvate kinase. 
pPK-NPS.  1 lag of the plasmid pUC13-NP3 was digested with Bst N1, 
repaired with the DNA polymerase large fragment, and a universal transla- 
tion terminator linker and an Eco RI linker were added to the repaired ends. 
The resulting Xho I-Eco RI fragment encoding amino acids 149-165  was 
purified from an acrylamide gel and ligated to the appropriate vector frag- 
ment to produce pPK-NP5. 
pPK-NP(x  1 lag of the plasmid pUCI3-NPI  was digested with Bst NI, 
repaired with DNA polymerase large fragment, and an Xho I linker was 
added to the repaired ends. The DNA preparation was then digested with 
Eco RI and the appropriate Xho l-Eco RI fragment encoding amino acids 
165-200 was purified from an acrylamide gel and ligated to the appropriate 
vector fragment to produce pPK-NP6. 
Bal 31 Deletion.  10 Ixg of the plasmid pUC13-NP3 was linearized with 
Eco  RI or Xho I.  The linear DNA  molecule was digested with Bal  31 
nuclease (New England Biolabs, Beverly,  MA) at 30°C for 8 min. Appro- 
priate linkers were added to the digested DNA and excess linkers were re- 
moved by restriction enzyme digestion. The linear plasmid was purified 
from an agarose gel, ligated to form circular molecules, and used to trans- 
form competent E. coli cmk 603. DNA was prepared from colonies of trans- 
formed cells and  screened by  restriction enzyme digestion.  Fragments 
showing a  reduction in size were sequenced and suitable deletions were 
ligated to the pyruvate kinase vector fragment to give the pPK-A series of 
plasmids. 
Minimal Sequence Constructs 
The Xho I-Eco RI fragments encoding the chosen deletions were subcloned 
into pUC13  and grown in NM545  (thr- leuB rpsL dam- dcm- [GM 48 
StaR]). The Xho I-Eco RII and Eco RII-Eco RI fragments from the cho- 
sen original deletions were ligated to the appropriate pyruvate kinase vector 
fragment in a three fragment ligation. An Xho I-Eco R1 fragment was ex- 
cised from the recombinants and sequenced to confirm their identity. 
Results 
Selective Entry Model for Nuclear Accumulation 
of  Proteins Is Applicable to Mammalian Cells 
We wished to determine if the selective entry model for nu- 
clear accumulation established in Xenopus oocytes (8) ap- 
plies to cultured mammalian cells since these cells were used 
in the analysis of the nuclear location sequence (see below). 
Therefore, as a prelude to these studies, the transport mecha- 
nism for nucleoplasmin was investigated by microinjection 
of unlabeled protein followed by detection with antibodies. 
Nucleoplasmin accumulates rapidly in the cell nucleus af- 
ter microinjection into the cytoplasm (Fig.  1 a).  To deter- 
mine  the  initial  rate  of nucleoplasmin  uptake,  cells  were 
cooled to 20°C, injected with protein, and rapidly fixed (Fig. 
1 b).  This would correspond to ",d  min after  the injection 
of the first cell in a group of cells.  A  number of cells show 
protein accumulation within the nucleus while in others the 
protein is predominantly cytoplasmic. This indicates that un- 
der normal conditions the bulk of the injected nucleoplasmin 
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min, the trypsin-resistant  core, and tail regions. 
Vero cells were microinjected with (a) nucleoplas- 
min into the cytoplasm, fixed, and stained after I h 
at  37°C; (b)  nucleoplasmin  into the  cytoplasm, 
fixed, and stained within  1 min after injection at 
20°C;  (c) trypsin-resistant  core of nucleoplasmin 
injected into the cytoplasm, fixed, and stained 1 h 
after  injection  at  37°C; (d)  the  12,000-Mr tail 
fragment of nucleoplasmin  injected into the cyto- 
plasm, fixed, and stained after 1 h at 37°C; (e) the 
trypsin-resistant  core  of nucleoplasmin  injected 
directly  into the nucleus, fixed, and stained after 
1 h at 37°C. 
would  accumulate  in  the  nucleus  in  <1  min.  In  some in- 
stances a distinct, sharply defined zone of increased staining 
is observed at the level of the nuclear envelope (Fig.  1 b). 
We and others have shown elsewhere, that inhibition of ATP 
generation reversibly blocks intranuclear accumulation but 
not perinuclear association, and on this basis have proposed 
a two step mechanism for the accumulation of proteins in the 
cell nucleus (27, 35).  The trypsin-resistant core of nucleo- 
plasmin  does  not  enter  the  nucleus  (Fig.  1  c)  while  the 
purified  tail  fragment does  (Fig.  1 d).  In  the  latter  case 
distinct punctate cytoplasmic fluorescence is observed and 
contrasts with the absence of cytoplasmic staining in cells in- 
jected with intact nucleoplasmin (compare Fig.  1, a  and d). 
The tail fragment may be unstable in these cells as it is in 
Xenopus  oocytes  and  the  fluorescent  spots  may  represent 
regions of protein turnover. 
In the Xenopus oocyte the decisive evidence for a selective 
entry mechanism for nuclear accumulation was the retention 
within the nucleus of the trypsin-resistant core of nucleoplas- 
min after direct microinjection into the nucleus  (8).  When 
the  same  experiment  was  performed  in  Vero  cells  the 
nucleoplasmin core molecule remains stably in the nucleus 
(Fig.  1 e). 
These experiments demonstrate that as in the Xenopus oo- 
cyte nucleoplasmin accumulates extremely rapidly in the cell 
nucleus  by  a  selective  entry  mechanism  and  not  by  free 
diffusion and binding  within the nucleus. 
Identification of a Region Encoding a Nuclear 
Location Signal (NLS) 
As mentioned above the sequence of a full-length nucleoplas- 
min cDNA has been determined and we have shown that the 
nucleoplasmin polypeptide is 200 amino acids long and the 
carboxy-terminal 50 amino acids constitute the tail region 
that specifies entry into the nucleus (7). In this region there 
are four sequences which are similar to nuclear location sig- 
nal sequences that have been identified in other nuclear pro- 
teins (6, 7). Two regions show close similarity to the SV-40 
large T  antigen  NLS  (37)  and two are similar to the  con- 
sensus sequence identified in the MAT o2 protein of yeast 
(13). 
Fig. 2 a  shows the location of these putative nuclear loca- 
tion sequences in the tail region and the position of selected 
restriction enzyme cleavage sites.  These sites were used to 
construct recombinant plasmids (Fig. 2 b) in which these se- 
Dingwall et al. The Nucleoplasmin Nuclear  Location Sequence  843 Figure 2. (a) Diagramatic representation of the tail region of nucleoplasmin. The bar represents amino acids 149-200 of the nucleoplasmin 
tail (7). Residue 200 is the carboxy terminus of nucleoplasmin.  Protein sequences similar to the MAT 02 consensus or the SV-40 nuclear 
location sequence are shown above. Restriction enzyme cleavage sites in the DNA are indicated by arrows below. (b) Structure and subcellu- 
lar location of nucleoplasmin/pyruvate kinase fusion proteins. The plasmid vectors listed on the left were made as described in Materials 
and Methods. The fusion proteins consist of  a major part of pyruvate kinase (solid bars) to which are linked sequences from the nucleoplas- 
min tail region (hatched bars). The subcellular location of the fusion protein listed on the right was determined by immunofluorescence 
assay after microinjection  of plasmid DNA into Vero cells. N, nuclear  location;  C, cytoplasmic location. 
quences are linked to the COOH terminus or NHz terminus 
of chicken muscle pyruvate kinase using the plasmid vector 
system described previously (15, 33).  The intracellular dis- 
tribution of the fusion protein expressed from each plasmid 
was examined by indirect immunofluorescence with antise- 
rum against pyruvate kinase and where possible with mono- 
clonal antibodies against the tail region of nucleoplasmin. 
When the carboxy-terminal 51 amino acids of nucleoplas- 
min (residues  149-200) that constitute the entire tail region 
are linked to the carboxyterminus of pyruvate kinase (plas- 
mid pPK-NP1), the fusion protein becomes located in the cell 
nucleus (Fig. 3). Both an antiserum against pyruvate kinase 
and a mixture of three monoclonal antibodies specific for the 
tail region of nucleoplasmin showed strong nuclear fluores- 
cence (Fig. 3, a  and a'). This result indicates that the entire 
nucleoplasmin tail  sequence  can locate PK to the cell  nu- 
cleus. 
In  pPK-NP2  the  carboxy-terminal  23  amino  acids  of 
nucleoplasmin (residues  178-200) are linked to the carboxy 
terminus of PK. The fusion protein expressed from this plas- 
mid was unable to locate to the cell nucleus as shown by the 
presence  of  cytoplasmic  fluorescence  with  antiserum  to 
pyruvate kinase (Fig. 3 b). The three tail-specific monoclo- 
nal antibodies did not give a fluorescent signal with the fu- 
sion protein. This lack of reaction and the inability of the fu- 
sion protein to locate to the cell nucleus is not due to linkage 
of the two DNA fragments in the incorrect reading frame as 
the same result was obtained when the nucleoplasmin frag- 
ment  was  linked  to  pyruvate  kinase  in  all  three  reading 
frames (data not shown) and agrees with the findings of Bur- 
glin and De Robertis (1) using 13-galactosidase. 
Therefore the sequence lying between amino acids 178 and 
200 of the nucleoplasmin tail region is unable to locate PK 
to the  cell  nucleus  even though  it contains  sequences that 
resemble previously  identified  nuclear  location  sequences 
(see above). Also the three monoclonal antibodies to nucleo- 
plasmin do not recognise an epitope in the 23 amino acids 
at the extreme COOH terminus of nucleoplasmin. 
In the plasmid pPK-NP3, amino acids 149-176  of nucleo- 
plasmin are linked to the COOH terminus of pyruvate kinase. 
The fusion protein expressed from this plasmid is located in 
the cell nucleus as indicated by staining with both the anti- 
serum to pyruvate kinase and the tail-specific anti-nucleo- 
plasmin monoclonal antibodies (Fig.  3, c and c'). This demon- 
strates that this region of nucleoplasmin contains a sequence 
which can locate pyruvate kinase to the cell nucleus. This re- 
gion has  also been shown to locate 13-galactosidase  to the 
Xenopus oocyte nucleus (1). In this 27-amino acid segment 
there is a sequence (residues  156-162) that shows a reason- 
able  similarity to  the  yeast MAT  02  consensus  and  a  se- 
quence (residues  166-172)  that is  strikingly  similar to the 
SV-40 large T antigen nuclear location sequence. These two 
sequences  encoded  within  the  nucleoplasmin  fragment in 
pPK-NP3 were separately linked to the COOH terminus of 
pyruvate kinase to give two plasmids,  pPK-NP4 and pPK- 
NP5  (Fig.  2  b).  Surprisingly the  fusion protein  expressed 
from either of these plasmids is located in the cell cytoplasm 
(Fig. 3, d and d'). The nucleoplasmin fragment in pPK-NP4 
which  encodes the  sequence  with closest similarity to the 
SV-40 nuclear location sequence is also unable to locate the 
fusion protein to the cell nucleus when linked to the amino 
terminus (pNP4-PK) rather than the carboxy terminus (Fig.  2; 
Fig.  3,  e  and e'). 
These fusions are directly comparable with those used to 
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cleoplasmin fusion proteins.  Plasmid DNAs encoding 
the fusion proteins  diagrammed in Fig.  2 b were in- 
jected into the nucleus of Vero cells.  Following injec- 
tion cells  were  incubated  overnight then  fixed  and 
stained  for pyruvate kinase  (a-e)  or nucleoplasmin 
(a'-e') as described in Materials  and Methods.  (a, a') 
pPK-NPI;  (b)  pPK-NP2;  (c,  c') pPK-NP3;  (d,  d') 
pPK-NP4; (e, e') pNP4-PK. No image is possible  for 
b' because no monoclonal antibody is available  that 
recognizes that fragment of nucleoplasmin. 
demonstrate  the  ability  of the  SV-40  nuclear  location  se- 
quence to locate pyruvate kinase to the cell nucleus.  There- 
fore we have demonstrated conclusively that the sequence in 
nucleoplasmin that is closely similar to the SV-40 nuclear 1o- 
cation sequence  is unable to locate PK to the cell nucleus 
when it is fused to either the amino or carboxy terminus of 
the protein. 
To establish that the sequence encoded in pPK-NP3 is the 
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capable of translocating pyruvate kinase to the cell nucleus 
we linked amino acids 165-200 of nucleoplasmin to the car- 
boxy terminus of pyruvate kinase (plasmid pPK-NP6 in Fig. 
2 b). The fusion protein expressed from this plasmid is lo- 
cated in the cell cytoplasm. 
We therefore undertook a detailed analysis of the region of 
nucleoplasmin (amino acids 149-176)  linked to pyruvate ki- 
nase  in  pPK-NP3  in  order  to  determine  precisely the  se- 
quence responsible for nuclear location. 
Deletion Analysis of the Nuclear Location Sequence 
The  DNA  fragment which  encodes  amino  acids  149-176 
of nucleoplasmin was treated with Bal 31 nuclease (see Ma- 
terials and Methods)  to generate molecules with deletions 
from either the 5' (amino) end or the 3' (carboxyl) end of this 
fragment.  The amino acid sequences  of the deletions pro- 
duced by this procedure and the subcellular location of the 
corresponding fusion protein are shown in Fig. 4  top. The 
immunofluorescence patterns observed for certain of the de- 
letions are shown in Fig. 4  bottom. 
Deletions from the Amino Terminus.  Analysis of dele- 
tions from the amino terminus (amino acid  149)  indicate a 
transition of the location of the fusion protein from nuclear 
to cytoplasmic when the deletion end point lies in the region 
of amino acid  157  (proline). 
In PK-A1 the fusion protein is nuclear (Fig. 4 bottom, a). 
The end point of this deletion lies at arginine residue  156. 
However the lysine residue  155 present in the original frag- 
ment is replaced in the deletion by an arginine residue en- 
coded by the  linker  DNA.  Therefore the  presence of two 
basic residues at this location is maintained; lys-arg-pro be- 
comes arg-arg-pro. 
In pPK-A4 the fusion protein is cytoplasmic (Fig. 4 bottom, 
b). The end point of this deletion lies at alanine residue 158. 
In  this  case  the  nucleoplasmin  sequence  lys-arg-pro  is 
Figure  4.  (Top) Deletion  analysis 
of the minimal  nuclear  location se- 
quence.  The plasmid  vectors  listed 
on the left were made as described in 
Materials and Methods. Nucleoplas- 
min sequences  (boxed) were linked 
to the COOH terminus  of pyruvate 
kinase.  Amino  acid  sequences  en- 
coded  by  linker  DNA  are  shown 
outside the boxed sequences.  Num- 
bers  indicate  amino  acids  in  the 
nucleoplasmin  sequence.  Subeellu- 
lar location of the fusion proteins (N, 
nuclear;  C, cytoplasmic) was deter- 
mined by immunofluorescence assay 
after microinjection of  plasmid DNAs 
into Vero cells. (Bottom) Subcellular 
location  of pyruvate  kinase/nucleo- 
plasmin  fusion  proteins.  Plasmid 
DNAs encoding the  fusion proteins 
shown in the top were microinjected 
into the cell  nucleus  of Vero cells. 
After overnight incubation the cells 
were fixed and stained for pyruvate 
kinase as described in Materials and 
Methods.  (a) pPK-A1; (b) pPK-A4; 
(c) pPK-A159; (d) pPK-AI90. 
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nuclear  location  of pyruvate kinase 
fusion proteins. The plasmid vectors 
listed on the left were made as de- 
scribed  in  Materials  and  Methods. 
Nucleoplasmin  sequences  (boxed) 
were linked to the carboxy terminus 
of pyruvate kinase.  Amino acid se- 
quences encoded by the linker DNA 
are  shown  outside  the  boxed  se- 
quences.  (Bottom) Subcellular loca- 
tion  of pyruvate  kinase/nucleoplas- 
min  fusion  proteins  carrying  the 
proposed  minimal  nuclear  location 
sequences.  Plasmid  DNA encoding 
the fusion protein  shown in the top 
were microinjected  into the nucleus 
of  Vero cells. After overnight incuba- 
tion the cells were fixed and stained 
for pyruvate kinase as described  in 
Materials  and  Methods.  (a)  pPK- 
A1/A159;  (b)  pPK-A2/A159;  (c) 
pPK-A1/A138; (d) pPK-A2/A138. 
replaced by ala-arg-gly encoded by the linker DNA. There- 
fore this deletion effectively generates two amino acid changes, 
lysine  155 is replaced by an alanine residue and proline ~57 is 
replaced by a  glycine residue. 
Therefore the  difference between pPK-A1  (nuclear)  and 
pPK-A4 (cytoplasmic) is the simultaneous replacement of a 
basic amino acid (lysine) by a neutral one (alanine) and of 
a  bend-forming amino acid (proline) by glycine. 
Deletion from the Carboxy Terminus.  Deletion of amino 
acids  from the carboxy terminus  (amino acid  176) reveals 
that only part of the lysine tract (residues 16%170) is neces- 
sary for location to the cell nucleus.  The fusion protein ex- 
pressed  from  pPK-A159  bears  amino  acids  149-169  of 
nucleoplasmin (Fig. 4 top) and three of the four contiguous 
lysine residues remain. This fusion protein is located in the 
cell nucleus (Fig. 4 bottom,  c),  however, when these three 
remaining lysine residues are removed (pPK-A190) the fu- 
sion protein is located in the cell cytoplasm (Fig. 4 bottom, d). 
This result clearly shows that within  the  context of this 
fragment, at most three of the four lysine residues are neces- 
sary for the location of pyruvate kinase to the cell nucleus, 
however, as described below the local sequence context of 
these deletions  influences their ability to locate the  fusion 
protein to the nucleus. 
Minimal Sequence for Nuclear Location 
The deletion analyses described above indicate that a mini- 
mal sequence of fourteen amino acids (amino acids 156-169) 
should be sufficient to locate pyruvate kinase to the cell nu- 
cleus. This minimal sequence was tested directly by linking 
a  fragment of DNA from pPK-A1  (nuclear located fusion 
protein) to a fragment of DNA from pPK-A159 (nuclear lo- 
cated fusion protein) through the common Eco RII site (Fig. 
5 top). 
Surprisingly we found that the pyruvate kinase fusion pro- 
tein bearing this proposal minimal sequence (pPK-A1/A159) 
was located in the cell cytoplasm (Fig.  5 bottom,  a). 
To determine which additional sequences were required to 
generate a  sequence which could locate pyruvate kinase to 
the  nucleus  we  restored  nuclcoplasmin  sequence  at  the 
amino-terminal end (pPK-A2/A159), the carboxyl-terminal 
end  (pPK-A1/A138),  or at both ends (pPK-A2/A138).  We 
found that the fusion proteins from all three plasmid con- 
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We observed some differences in the extent of nuclear loca- 
tion.  The fusion protein expressed from plasmid pPK-A2/ 
A138 was exclusively nuclear while the fusion proteins ex- 
pressed from plasmids pPKAI/AI38 and pPKA2/A159 gave 
some cytoplasmic staining  in  a  number of cells  (data  not 
shown). 
Therefore this analysis shows that the proposed minimal 
sequence constitutes a necessary element in sequences that 
can locate the fusion protein to the cell nucleus. However this 
sequence  element is  not  sufficient for transport and addi- 
tional amino acids are required at either end for efficient nu- 
clear location. 
Discussion 
Selective Entry Model for Nuclear Accumulation 
Is Applicable to Cultured Mammalian Cells 
As a prerequisite for further studies we have established that 
nucleoplasmin accumulates in the nucleus of Vero cells by 
the same general mechanism as it accumulates in the germi- 
nal vesicle of the Xenopus oocyte despite the fact that the two 
types of cell are markedly different in terms of their nuclear 
architecture and composition (10). 
The rapid rate of accumulation of nucleoplasmin that we 
have observed is greater than that reported for fluorescently 
labeled  nucleoplasmin  in  hepatoma tissue  culture  hetero- 
karyons (34). We feel that this difference is probably due to 
the chemical modification of lysine residues by their fluoro- 
chrome leading to reduced efficiency of the nuclear location 
sequence. 
None of  the Putative Nuclear Location Sequences 
in the Tail Region Can Locate Pyruvate Kinase to the 
Cell Nucleus 
As mentioned above we chose the pyruvate kinase vector sys- 
tem to analyse the nuclear location sequence in nucleoplas- 
min because of the wealth of data that has been accumulated 
for the SV-40 and polyoma virus large T antigen nuclear lo- 
cation sequences using this system. The advantage of pyru- 
vate kinase is its exclusively cytoplasmic distribution while 
the structural data available for the closely homologous cat 
muscle enzyme (26)  indicates that the carboxy and amino 
termini are both exposed in the monomer and are ideal loca- 
tions for the placement of a nuclear location sequence. E. coli 
13-galactosidase  has been used as a marker protein for several 
studies of nuclear location sequences (1,  13,  25,  36).  How- 
ever, 13-galactosidase  enters the nucleus of cells to some ex- 
tent (15) complicating the assay by producing a background 
level against which the activity of any putative nuclear loca- 
tion sequence must be assessed. 
The investigations described here have led to the surpris- 
ing finding that none of the four sequences in the nucleoplas- 
min  tail  region  that  resemble other  nuclear  location  se- 
quences are able to locate pyruvate kinase to the cell nucleus. 
In particular, one of these sequences differs from the SV-40 
large T antigen nuclear location sequence at two amino acid 
positions, both of which have been mutated individually and 
shown not to influence nuclear accumulation of large T (37). 
However we find that this similar sequence from nucleoplas- 
min is unable to locate pyruvate kinase to the cell nucleus 
whether it is linked to the amino acid or carboxy terminus 
of the protein. Instead we have demonstrated that a single se- 
quence able to locate pyruvate kinase to the cell nucleus lies 
between amino acids 149 and 176, in the amino-terminal 28 
amino acids of the tail region. 
Minimal Sequence of 14 Amino Acids Is Revealed 
by Deletion Analysis 
Deletion analysis of the 28 amino acid segment able to locate 
pyruvate kinase to the nucleus allowed us to define the limits 
of a nuclear location sequence. 
Deletion of amino acids from the amino terminus of this 
segment showed that a transition in the location of the fusion 
protein  from  nuclear  to  cytoplasmic  is  concomitant  with 
simultaneous  substitution  of lysine  ~55 by alanine,  and pro- 
line Is7 by glycine.  Both of these substitutions  are noncon- 
servative; a positively charged residue (lysine) is replaced by 
a hydrophobic amino acid (alanine) and proline, which fixes 
the conformation of the polypeptide backbone, is replaced 
by glycine which permits maximum flexibility. Analysis of 
single mutations in the sequence is required to determine the 
individual contribution of these two amino acid substitutions 
to the transport defect. 
Deletion of amino acids from the carboxy terminus of this 
segment removes lysine residues which are part of the se- 
quence showing greatest similarity to the SV-40 large T anti- 
gen nuclear location sequence. Removal of the most carboxy- 
terminal lysine residue does not abolish transport into the 
cell nucleus but removal of the next three does. This shows 
that at most three basic amino acids are needed at this end 
of the sequence for efficient nuclear location. 
However,  the  minimal  sequence  defined  by  these  end 
points (RPAATKKAGQAKKK) is unable to locate pyruvate 
kinase to the cell nucleus, indicating that the context within 
which  this  sequence  is  presented  influences  its  activity. 
Thus,  restoration  of  three  amino  acids  of  the  original 
nucleoplasmin  sequence  at either  the  amino- or carboxy- 
terminal  end  of  this  minimal  sequence  (or  both  ends) 
produces  sequences that can locate pyruvate kinase to the 
cell nucleus.  Therefore the  functional nuclear location se- 
quences contain the proposed minimal sequence as a neces- 
sary central sequence element. This sequence has periodic 
structure in which two sequences of four hydrophobic resi- 
dues separate three basic regions. 
It is notable that the  functional  sequences contain a  se- 
quence showing similarity to the yeast MAT 02 nuclear loca- 
tion sequence and the sequence having the closest similarity 
to the SV-40 large T  antigen nuclear location sequence. 
The unusual finding that restoring sequences at one end or 
the other is sufficient to generate a functional nuclear loca- 
tion sequence suggests models for the interaction of this se- 
quence with a putative receptor in the nuclear transport ma- 
chinery.  We will briefly consider three. 
First, it could be envisaged that the termini of the minimal 
sequence defined by the deletions described above represent 
two discrete binding domains that interact with correspond- 
ing binding sites in the receptor. Disruption of one binding 
domain can be tolerated but only as long as the other domain 
is maintained intact. A sequence in which both domains are 
disrupted cannot locate the fusion protein to the cell nucleus 
due to the combinatorial effect of weak binding at both sites. 
Secondly, the nucleoplasmin-receptor interaction may not 
be limited to distinct sites but could occur over an extended 
region which includes these sites. Weak interaction at either 
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both ends reduces the overall binding to a level that renders 
the sequence inactive. In this case amino acids in the central 
region of this sequence would be expected to play a signifi- 
cant role in the function of this sequence. 
Third, a precise conformation is necessary for recognition 
and transport and only the longer sequences can assume this 
conformation. 
These models can be tested by in vitro mutagenesis. 
Comparison with Other Nuclear Location Sequences 
The  properties  of the  nucleoplasmin  nuclear  location  se- 
quence described here are unusual but there are indications 
that other nuclear location sequences may have similar fea- 
tures. In the case of N1, another abundant, acidic Xenopus 
nuclear protein also involved in chromatin assembly (4,  16, 
18), there is a sequence which closely resembles the SV-40 
nuclear location sequence  (17).  As  in nucleoplasmin,  this 
similar sequence is not sufficient to locate the protein to the 
nucleus. Further amino acids are required that provide addi- 
tional positively charged residues in a manner analogous to 
nucleoplasmin (16a). 
In bovine HMG  1 (29)  there is a  sequence that bears a 
striking resemblance to the nucleoplasmin nuclear location 
sequence identified here. This sequence is KKGVVKAEK- 
SKKKK,  compared  with  (AVK)RPAATKKAGQAKKK 
(KLD) in nucleoplasmin and lies on the amino-terminal side 
of the polyglutamic acid tract. 
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